Sova Pharmaceuticals Overview
- Year Founded
-
2010

- Status
-
Out of Business
- Employees
-
10

- Latest Deal Type
-
Out of Business
Sova Pharmaceuticals General Information
Description
Developer of innovative therapeutics designed for the treatment of inflammatory and neuropathic pain. The company's platform inhibits the production of H2S by blocking cystathionine-γ-lyase (CSE) activity to reduce pain signaling for postherpetic neuralgia, chemotherapy-induced peripheral neuropathic pain (CIPN pain), enabling patients to undergo a painless neuropathic treatment.
Contact Information
Website
www.sovapharma.comCorporate Office
- 11099 North Torrey Pines Road
- Suite 290
- La Jolla, CA 92037
- United States
Corporate Office
- 11099 North Torrey Pines Road
- Suite 290
- La Jolla, CA 92037
- United States
Sova Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Out of Business | 31-Oct-2023 | Completed | Out of Business | |||
2. Early Stage VC (Series A) | 10-Jan-2012 | Completed | Startup | |||
1. Accelerator/Incubator | Completed | Startup |
Sova Pharmaceuticals Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A |
Sova Pharmaceuticals Comparisons
Industry
Financing
Details
Sova Pharmaceuticals Competitors (15)
One of Sova Pharmaceuticals’s 15 competitors is AlgoTx, a Venture Capital-Backed company based in Suresnes, France.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
AlgoTx | Venture Capital-Backed | Suresnes, France | ||||
Regenacy Pharmaceuticals | Venture Capital-Backed | Waltham, MA | ||||
viDA Therapeutics | Venture Capital-Backed | Vancouver, Canada | ||||
Cortalix | Venture Capital-Backed | Groningen, Netherlands | ||||
Virometix | Venture Capital-Backed | Schlieren, Switzerland |
Sova Pharmaceuticals Patents
Sova Pharmaceuticals Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20150202186-A1 | Cystathionine-(gamma)-lyase (cse) inhibitors for treating pain | Inactive | 23-Jan-2014 | ||
EP-3096755-A2 | Cystathionine-(gamma)-lyase (cse) inhibitors for treating pain | Inactive | 23-Jan-2014 | ||
EP-3096755-A4 | Cystathionine-(gamma)-lyase (cse) inhibitors for treating pain | Inactive | 23-Jan-2014 | ||
AU-2013293090-A1 | Cystathionine-y-lyase (cse) inhibitors | Inactive | 25-Jul-2012 | ||
AU-2013293089-A1 | Cystathionine-y-gamma-lyase (cse) inhibitors | Inactive | 25-Jul-2012 | C07D257/04 |
Sova Pharmaceuticals Signals
Sova Pharmaceuticals FAQs
-
When was Sova Pharmaceuticals founded?
Sova Pharmaceuticals was founded in 2010.
-
Where is Sova Pharmaceuticals headquartered?
Sova Pharmaceuticals is headquartered in La Jolla, CA.
-
What is the size of Sova Pharmaceuticals?
Sova Pharmaceuticals has 10 total employees.
-
What industry is Sova Pharmaceuticals in?
Sova Pharmaceuticals’s primary industry is Biotechnology.
-
Is Sova Pharmaceuticals a private or public company?
Sova Pharmaceuticals is a Private company.
-
What is Sova Pharmaceuticals’s current revenue?
The current revenue for Sova Pharmaceuticals is
. -
How much funding has Sova Pharmaceuticals raised over time?
Sova Pharmaceuticals has raised $8.55M.
-
Who are Sova Pharmaceuticals’s competitors?
AlgoTx, Regenacy Pharmaceuticals, viDA Therapeutics, Cortalix, and Virometix are some of the 15 competitors of Sova Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »